These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 4297581)
41. The influence of dietary factors on the risk of urinary stone formation. Hesse A; Siener R; Heynck H; Jahnen A Scanning Microsc; 1993 Sep; 7(3):1119-27; discussion 1127-8. PubMed ID: 8146611 [TBL] [Abstract][Full Text] [Related]
42. [New views on the therapy of urolithiasis]. Bianchi F Helv Chir Acta; 1971 Dec; 38(5):491-3. PubMed ID: 5152159 [No Abstract] [Full Text] [Related]
43. [Crystallization inhibitory substances in urine and kidney calculi]. Baumann JM; Ganz U; Felix R; Fleisch H; Rutishauser G Helv Chir Acta; 1974 Sep; 41(4):417-20. PubMed ID: 4369523 [No Abstract] [Full Text] [Related]
44. Symposium on renal lithiasis. Medical evaluation of urolithiasis. Etiologic aspects and diagnostic evaluation. Smith LH Urol Clin North Am; 1974 Jun; 1(2):241-60. PubMed ID: 4372766 [No Abstract] [Full Text] [Related]
45. [The value attached to clinical laboratory findings in urolithiasis (author's transl)]. Zechner O; Höltl G; Zekoff K; Zekert F Wien Klin Wochenschr; 1974 Nov; 86(21):654-7. PubMed ID: 4428778 [No Abstract] [Full Text] [Related]
50. Symposium on renal lithiasis. The analysis of urinary calculi. Prien EL Urol Clin North Am; 1974 Jun; 1(2):229-40. PubMed ID: 4610942 [No Abstract] [Full Text] [Related]
51. Enzymic measurement of urinary pyrophosphate with a centrifugal analyzer. Roullet JB; Lacour B; Ulmann A; Bailly M Clin Chem; 1982 Jan; 28(1):134-7. PubMed ID: 6276045 [TBL] [Abstract][Full Text] [Related]
52. [Pathogenesis and diagnosis of urolithiasis in the light of studies on calcium, magnesium and phosphate metabolism as well as on urine surface tension]. Bocian J; Wochna Z; Pacholuk U Pol Przegl Chir; 1969 Aug; 41(8):Suppl 8a:1103+. PubMed ID: 5343558 [No Abstract] [Full Text] [Related]
53. The effects of magnesium and pH on experimental calcium oxalate stone disease. Borden TA; Lyon ES Invest Urol; 1969 Jan; 6(4):412-22. PubMed ID: 5773525 [No Abstract] [Full Text] [Related]
54. [Sodium excretion in children with lithogenic disorders]. Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402 [TBL] [Abstract][Full Text] [Related]
55. Phosphate metabolism and renal calcium stone disease. Wikström B Scand J Urol Nephrol Suppl; 1981; 61():1-56. PubMed ID: 6274003 [TBL] [Abstract][Full Text] [Related]
56. URINARY PYROPHOSPHATE AND UROLITHIASIS. RUSSELL RG; EDWARDS NA; HODGKINSON A Lancet; 1964 Jun; 2(7348):1446. PubMed ID: 14149185 [No Abstract] [Full Text] [Related]
57. [Study of the auto-antibodies in phospho-calcic renal calculi]. KEUTEL HJ Rein Foie; 1962 Jun; 4():II/175-8. PubMed ID: 14455452 [No Abstract] [Full Text] [Related]
58. The renal papilla and calculogenesis. Vermeulen CW; Lyon ES; Ellis JE; Borden TA J Urol; 1967 Apr; 97(4):573-82. PubMed ID: 6022425 [No Abstract] [Full Text] [Related]
59. Isolation and identification of some urinary inhibitors of calcium phosphate formation. Sutor DJ; Percival JM; Doonan S Clin Chim Acta; 1978 Oct; 89(2):273-8. PubMed ID: 213213 [TBL] [Abstract][Full Text] [Related]
60. Urinary pyrophosphate excretion in stone formers. Singh DP; Teotia M; Teotia SP; Nath M Indian J Med Res; 1985 Oct; 82():341-5. PubMed ID: 3000936 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]